NPY and Alzheimer disease: As inhibitory neurotransmitters gamma‐aminobutyric acid (GABA), glycine, and neuropeptide Y are released from neurons that form symmetric synapses in the IC, the robust loss of these synapses may contribute to central gain and presbycusis during AD.